(Q84335968)

English

Therapy: Targeted but not trouble-free: efalizumab and PML

scientific article published on 01 August 2009

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19648939

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648939%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

title

Therapy: Targeted but not trouble-free: efalizumab and PML (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19648939

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648939%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

1

Eamonn S Molloy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19648939

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648939%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

author name string

Leonard H Calabrese

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19648939

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648939%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

publication date

1 August 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19648939

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648939%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

published in

Nature Reviews Rheumatology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19648939

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648939%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

volume

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19648939

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648939%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19648939

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648939%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

page(s)

418-419

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19648939

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19648939%20AND%20SRC:MED&resulttype=core&format=json

retrieved

4 February 2020

exact match

https://scigraph.springernature.com/pub.10.1038/nrrheum.2009.142

0 references

cites work

Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.142

retrieved

31 March 2020

Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.142

retrieved

31 March 2020

Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.142

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.142

retrieved

31 March 2020

Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19648939

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progressive multifocal leucoencephalopathy in the rheumatic diseases: assessing the risks of biological immunosuppressive therapies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19648939

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q84335968)

Therapy: Targeted but not trouble-free: efalizumab and PML

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)